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Crystal-associated nephropathy in patients with brushite
nephrolithiasis.
Background. We have biopsied the renal cortex and papillae
of patients who form brushite renal stones asking if this un-
usual stone type is associated with specific tissue changes. We
contrasted these with biopsies of 15 calcium oxalate stone form-
ers, three stone formers with intestinal bypass, and four normal
subjects.
Methods. We studied all ten brushite stone formers treated
with percutaneous nephrolithotomy (PNL) during the past
3 years using digital video imaging of renal papillae, and ob-
tained cortical and papillary biopsies. Biopsies were analyzed
by light and electron microscopy, microinfrared spectroscopy,
and electron diffraction.
Results. Apatite crystals plugged scattered terminal collect-
ing ducts whose cells were injured or dead, and surrounding
interstitium inflamed and fibrotic. White papillary deposits of
interstitial apatite particles, so called Randall’s plaque, were
also present. Glomerular changes and cortical tubular atrophy
and interstitial fibrosis were moderate to severe.
Conclusion. Brushite stone formers combine the interstitial
plaque of calcium oxalate stone formers with the collecting duct
apatite plugs found in stone formers with intestinal bypass. Col-
lecting duct injury and interstitial fibrosis are severe. Promi-
nent cortical fibrosis, tubule atrophy, and glomerular pathology
seem secondary to the collecting duct plugging. We believe crys-
tallization obstructs and destroys terminal collecting duct seg-
ments thereby damaging nephrons, perhaps via intranephronal
obstruction, and producing a hitherto unrecognized renal
disease.
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About 5% of people form renal stones usually made
of calcium oxalate [1]. In biopsy samples taken during
percutaneous nephrolithotomy (PNL) we have found
that the common calcium oxalate stone formers produce
interstitial apatite particles that form the well-known
Randall’s plaques [2], but do not damage epithelial cells
or cause interstitial inflammation or fibrosis. Among
stone formers with intestinal bypass for obesity we found
no plaque, but some terminal collecting duct lumens were
plugged with apatite crystals associated with epithelial
cell damage and inflammation and fibrosis of the sur-
rounding interstitium. In other words, the two kinds of
stone formers displayed specific pathologies.
About 15% of stone formers produce predominantly
(>50%) calcium phosphate stones; of these, one fourth
form stones containing brushite (CaHPO4) [3]. We report
here renal papillary morphology and histopathology of
all ten brushite stone formers we have treated with PNL
during the past 3 years. Like calcium oxlate stone form-
ers, brushite stone formers have interstitial plaque. Like
bypass stone formers, they have apatite crystallization
within terminal collecting duct, associated with collect-
ing duct cell death, and papillary interstitial inflamma-
tion and fibrosis. In other words, their pathology is an
amalgam of calcium oxalate and bypass stone disease;
but collecting duct plugging and cell injury are far more
severe, as is interstitial inflammation and fibrosis.
The severity of the collecting duct and papillary in-
terstitial disease led us to evaluate cortical injury in the
brushite stone formers and compare it to our prior cal-
cium oxalate and bypass stone formers and nonstone
forming controls, asking if the more severe papillary in-
jury among brushite stone formers leads to proportion-
ately more severe glomerular changes, tubule atrophy,
and interstitial fibrosis. The papillary and cortical abnor-
malities in brushite stone formers are in fact so marked
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Table 1. Clinical characteristics of biopsied patients
Age first Number of Number of
Case Gender stone stones ESWL PNL procedures Age at Bx %brushite Relatives
1 F 42 2 1 (1) 1 (1) 2 (2) 42 100 (100) 6 (1)
2a F 14 25 11 (5) 1 (1) 13 (6) 42 70 (100) 13 (1)
3 F 18 >30 11 (8) 1 (1) 29 (18) 59 0 (100) 16 (5)
4b M 7 23 10 (9) 1 (1) 16 (13) 23 98 (100) 3 (1)
5 M 31 30 3 (2) 2 (1) 11 (6) 42 0 (65) n/a
6 M 17 >30 5 (3) 2 (2) 14 (10) 64 98 (100) 13 (8)
7c M 45 10 0 1 (1) 7 (7) 52 0 (100) 3 (2)
8 M 18 18 6 (4) 5 (2) 23 (11) 31 0 (100) 3 (1)
9 F 22 10 5 (2) 0 9 (6) 44 0 (100) 7 (1)
10d M 28 9 1 (1) 4 (3) 10 (8) 39 100 (100) 1 (1)
Abbreviations: Br, . . . ; stones, number of stones before Bx; ESWL, extracorporeal shock wave lithotripsy before bx (Bx side); PNL, percutaneous nephrolithotomy
before Bx (Bx side); procedures, total of all procedures (includes ESWL, PNL, ureteroscopy, open surgery, cystolithopaxy) before Bx (Bx side); %brushite, percent
brushite in first available analysis (% in most recent analysis); relatives, number of first degree relatives (number with stones).
aCase 2 had high blood pressure, multiple urinary tract infections.
bCase 4 had dismembered pyeloplasty age 4 for ureteropelvic junction obstruction, first stone soon after.
cCase 7 was chronic uric acid stone former and received extensive potassium citrate treatment for stone dissolution and formed a brushite stone.
dCase 10 was rendered c4/5 quadriplegic at age 22; multiple pseudomonas urinary tract infections treated mainly with aminoglycosides.
as to constitute a significant and hitherto unrecognized
renal disease not present in calcium oxalate or bypass
stone formers. Although mechanisms are not as yet en-
tirely clear, crystal formation seems a reasonable initi-
ating cause, with consequent collecting duct cell injury,
eventual destruction of terminal collecting duct segments,
and resulting nephron damage and loss.
METHODS
Subjects
We studied ten brushite stone formers, who represent
all calcium phosphate stone formers requiring PNL at
our institution in a 3-year period. Clinical history was
obtained, along with reviews of old records to obtain
stone analyses and type and number of stone procedures
(Table 1). In every case, the most recent stone con-
tained 65% or more brushite. In addition, we analyzed
renal cortical pathology of 15 calcium oxalate stone for-
mers, three patients with calcium oxalate stones after in-
testinal bypass for obesity, and four nonstone forming
patients, who had undergone nephrectomy for other rea-
sons. Medullary pathology and plaque mapping of these
22 nonbrushite stone formers have been reported previ-
ously [2].
Clinical laboratory studies
Two 24-hour urine samples were collected while pa-
tients were on a random diet for measurement of vol-
ume, pH, calcium, oxalate, citrate, phosphate, uric acid,
sodium, potassium, magnesium, sulfate, and ammonia
[4]. We calculated supersaturations with respect to cal-
cium oxalate, brushite, and uric acid using EQUIL 2 [4].
Routine clinical blood samples drawn in the absence of
treatments for stone disease served to exclude hyper-
parathyroidism and overt renal tubular acidosis [5] and
to estimate creatinine clearance.
Biopsy protocol
All ten brushite stone formers underwent PNL for
stone removal. Once the collecting system was free of
stone and debris, each papillum was visualized using ei-
ther a rigid or flexible nephroscope. Video footage of each
papillum was recorded on S-VHS or DVD format tape
and used to evaluate papillary morphology. Subsequently,
biopsies were taken from one selected papilla in each of
the upper, middle, and lower polar regions of the kidney
using a 5 F cup biopsy forceps. At the end of the PNL
procedure a biopsy was obtained from the outer cortex
using the same biopsy forceps, not necessarily associated
with the region of the papillary biopsy. In one patient
we were unable to obtain cortical tissue. As we have re-
ported for the prior cases [6] no biopsy site inspected in-
traoperatively displayed significant hemorrhage, and no
postoperative complications related to the biopsy pro-
cess occurred in any patient. The study was approved by
the Institutional Review Board Committee for Clarian
Health Partners (#98–073) and conducted according to
Declaration of Helsinki principles. Each subject gave in-
formed consent.
Gross papillary morphology
Using video footage recorded during the PNL access
procedure, we evaluated architectural distortions and
quantified the area of each papilla covered by pits. Pits are
depressions or concavities, usually associated with dilated
openings of ducts of Bellini near the papillary tip, but oc-
casionally at the side of a papillary wall. Using the intra-
operative recordings [7], total surface area of each papilla
was measured, and one of us (J.L.), in a masked man-
ner (i.e., without knowledge of the particular patient),
578 Evan et al: Brushite nephropathy
outlined areas of pitting on one set of prints. The pitted
and total papillary areas were converted to numbers of
pixels, giving the ratio of pitted to total papillary pixels,
or percent coverage with pitted regions.
Tissue analysis
General. Fifty-eight papillary and nine cortical biop-
sies were studied using light and transmission electron
microscopy (TEM). Papillary and cortical biopsy speci-
mens were immediately immersed in 5% paraformalde-
hyde in 0.1 mol/L phosphate buffer (PPB) (pH 7.4). Four
additional papillary biopsy specimens were immersed in
100% ethanol (ETOH). All specimens were refrigerated
for three or more days following the initial fixation.
Light microscopic analysis. Papillary and cortical
biopsies fixed in PPB were dehydrated through a series
of graded ethanol concentrations to ETOH prior to em-
bedment in a 50/50 mixture of Paraplast Xtra (Fisher,
Itasca, IL, USA) and Peel-away Micro-Cut (Polysciences,
Warrington, PA, USA). Papillary biopsies fixed in ETOH
were directly embedded in a 50/50 mixture of Paraplast
Xtra (Fisher) and Peel-away Micro-Cut (Polysciences).
Twelve serial sections were cut at 4 l and stained with the
Yasue metal substitution method for calcium histochem-
istry [8], hematoxylin and eosin for routine histologic ex-
amination or Jones’silver stain for the semiquantitation
of glomerulosclerosis. An additional set of serial sections
was cut at 7 l for infrared analysis.
In a double-blind design, two renal pathologists (C.P.
and S.B.) performed a semiquantitative analysis on the
Jones’ silver stained cortical sections from nine of the
ten brushite patients, as well as the four controls, 15 cal-
cium oxalate stone formers, and three of the four bypass
stone formers from our prior study [2, 3]. Tubular atro-
phy and interstitial fibrosis were independently scored
on a scale of 0 to 3 (0, none; 1, mild or <34% of sample;
2, moderate or 34% to 66%; and 3, severe or >66%).
Glomerulosclerosis was defined as increased mesangial
matrix with or without wrinkling, thickening and/or col-
lapse of glomerular basement membranes. Sclerosis of in-
dividual glomeruli was scored as segmental (<25%, mild;
25% to 75%, moderate) or global (>75%, severe or total
obsolescence). The total number of glomeruli observed
and the number of glomeruli in each of the three cate-
gories of sclerosis were recorded. In all cases, we allowed
one degree of grading difference between observers. For
greater differences, the tissue was reassessed blindly by
offering other sections from the same biopsy to both re-
viewers.
Infrared. We used attenuated total internal reflection
(ATR) Fourier transform infrared microspectroscopy
(l-FTIR) to determine the mineral composition of the
sites of crystal deposits. Infrared spectra were collected
with a Perkin-Elmer Spotlight 300 infrared microscope
interfaced to a Perkin Elmer Spectrum One FTIR Spec-
trometer. The system employed a 100 × 100 lm, liquid
nitrogen cooled, mercury cadmium telluride (HgCdTe)
detector. The standard germanium internal reflection el-
ement was employed in conjunction with a 100 × 100 l
aperture. The ATR method is, in general, an immersion
microscopy method, which improves the spatial (x, y,
and z) resolution of the microscopic measurement. The
combination of the germanium internal reflection ele-
ment and the aperture yields a 25 × 25 lm sample area.
Each spectrum represents the average of 64 individual
scans possessing a spectral resolution of 4 cm−1. Seven-
micrometer thick paraffin sections and standards that
included Virginia brushite and calcite (form of calcium
carbonate) from Excalibur Mineral Company (Peekskill,
NY, USA), calcium oxalate monohydrate from Alfa
Products (Danvers, MA, USA), and calcium hydroxyap-
atite from Spectrum Chemical (Gardena, CA, USA) were
analyzed according to our previously published protocol
[2].
TEM. The 5 mm PPB fixed biopsy specimens of the
renal papilla were divided into 1 mm blocks and either
routinely processed for TEM or placed in a decalcifi-
cation solution before embedment. Those tissue blocks
routinely processed for TEM were first rinsed in PPB,
and then dehydrated through a series of graded ethanol
concentrations to ETOH, passed through two changes
of propylene oxide before embedment in Epon 812.
Those tissue blocks used for decalcification studies were
first placed in 0.1 mol/L ethylenediaminetetraacetic acid
(EDTA) for 2 months with daily changes of fresh solu-
tion and then processed through the ethanol sequence
noted above and propylene oxide. Thick sections (∼1 lm)
were stained with toludine blue, whereas the thin sections
(∼0.04 lm) were stained with uranyl acetate and lead cit-
rate. All thin sections were examined with a Philips 400
electron microscope.
Electron diffraction. The structure of the crystalline
material in the papillary tissue of one brushite stone
former was determined by TEM electron diffraction.
The analysis was performed with a Philips Tecnai 20 at
100 kV and with a diffraction camera length of 890 mm.
This sample had been routinely fixed for TEM but not
stained.
Statistics
Twenty-four–hour urine brushite stone former was
compared to equivalent measurements from 57 brushite
stone formers and 830 calcium oxalate stone formers pre-
sented elsewhere [3]. This comparison is not intrinsic
to the principal aims of the present work, but is meant
to characterize this particular patient group in relation
to other larger corresponding groups. For this reason,
we simply provide group means, standard errors, and
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Table 2. Selected laboratory data compared to prior reference populations
Serum Serum Creatinine Urinary Urinary Urinary Supersaturation
creatinine Serum chloride clearance volume calcium citrate calcium
Case Gender mg/dL CO2 mEg/L mL/min Urine pH L/24 hours mg/24 hours mg/24 hours phosphate
1 F 0.9 28 102 73 5.45 0.53 250 96 2.5
2 F 0.7 29 104 144 6.12 1.8 355 83 2.2
3 F 1.2 24 106 72 5.8 1.1 339 160 2.6
4 M 1.3 26 108 106 6.15 1.15 166 132 1.9
5 M 1.3 28 103 77 6.46 1.45 316 429 3.3
6 M 1.3 30 100 93 6.22 2.07 273 62 1.6
7 M 0.9 27 104 138 5.47 1.37 380 496 1.0
8 M 1.1 29 103 94 6.67 2.63 333 237 1.4
9 F 0.8 26 106 170 6.13 3.17 804 1421 2.6
10 M 0.7 27 99 233 6.22 2.37 199 451 0.7
Mean M 1.1 ± 0.1 27 ± 1 103 ± 1 123 ± 23 6.22 ± 0.2 1.8 ± 0.2 278 ± 33 301 ± 75 1.7 ± 0
F 0.9 ± 0.1 26 ± 1 104 ± 1 115 ± 25 5.88 ± 0.2 1.6 ± 0.6 437 ± 125 440 ± 327 2.5 ± 0
Brushite stone formers M (1.01–1.11) (27–28) (106–108) (119–140) (6.2–6.4) (1.8–2.3) (295–369) (407–578) (2.1–2)
F (0.79–0.91) (25–27) (105–108) (94–117) (6.1–6.4) (1.3–1.8) (183–273) (264–494) (1.5–2)
Calcium oxalate stone M (1.04–1.07) (27–28) (106–107) (125–129) (5.9–6.02) (1.67–1.78) (242–258) (521–569) (1.4–1)
formers
F (0.82–0.86) (26–27) (107–108) (98–106) (5.9–6.05) (1.3–1.5) (190–216) (476–558) (1.4–1)
Abbreviations: Mean, mean values by gender for present cases (± SEM); M, males; F, females. Data from reference populations in parentheses; are shown below
the present subjects; brushite stone formers, 40 males and 17 females from prior studies; calcium oxalate stone formers, 625 males and 205 females from prior studies;
values for brushite and calcium oxalate stone formers are 95% confidence intervals.
95% confidence intervals for the larger groups and all
individual data for the present group, which allows direct
inspection and comparison.
Renal cortical pathology was graded as glomerular
changes mild, moderate, or severe, and interstitial fibro-
sis and atrophy. For analysis, we calculated percent of
glomeruli with moderate or severe change for each sub-
ject (percent glomerular pathology), and added together
the scores for interstitial fibrosis and tubular atrophy to
give a single score (atrophy/fibrosis score). Using analy-
sis of variance (ANOVA), each score was separately an-
alyzed to evaluate differences between the four groups
(brushite, calcium oxalate, bypass, and normal), allow-
ing for age, and number of extracorporeal shock wave
lithotripsy (ESWL) treatments, as confounders. The cross
product of ESWL and group was estimated to determine
homogeneity of slopes for both comparisons. Post hoc
analysis of differences between groups for each score was
performed using adjusted variables. Conventional soft-
ware was used (Systat, Point Richmond, CA, USA).
RESULTS
Clinical and laboratory characteristics resemble those
of other stone former populations
At the time of study patients were 23 to 59 years of
age (Table 1). Some had many ESWL, PNL, and en-
doscopic procedures. Serum creatinine, total CO2, and
chloride levels were normal (Table 2). Selected urine
chemistries do not differ remarkably from those of our
prior 57 brushite stone formers, or our prior 830 calcium
oxalate stone formers [3]. The relatively high urine vol-
ume and calcium excretions, and low citrate excretions
compared to calcium oxalate (Table 2) are as one expects
[3].
Kidney papillae show three kinds of deposits
We observed three patterns of deposit in each of the ten
patients. The first pattern is suburothelial white lesions
around the openings of ducts of Bellini at the papillary
tip (Figs. 1 and 2) that Randall named “type 1” plaque
[9]. Such plaque is common on papillae of calcium ox-
alate stone formers occurs in traces on papillae of non-
stone formers, and is an interstitial deposit of apatite par-
ticles [2, 9]. The second pattern is large yellow deposits
that project from the openings of ducts of Bellini into
the urinary space (Fig. 1A and B), and resemble “type 2”
Randall’s plaque [9, 10]. The third pattern is suburothelial
yellow deposits, of variable size, on the sides of papillary
tips, away from ducts of Bellini (Figs. 1B and 2A and B).
We term these “type 3” for convenience. The larger type
3 deposits are elongate and form a spoke and wheel pat-
tern around the circumference of the papilla, extending
from the papillary tip to the fornix (Fig. 2A). Types 2 and
3 deposits were never encountered in calcium oxalate or
bypass stone formers, or nonstone former controls [2].
White and yellow papillary deposits have contrasting
histologic characteristics
Type 1 plaque was interstitial apatite deposit (Figs. 1B
and 2D) exactly like those we [2] described in calcium
oxalate stone formers. This is an expected finding, in that
the white suburothelial plaque in these ten patients ap-
peared identical to the white plaque of calcium oxalate
stone formers we [2] and others [9–12] have described.
Yellow deposits at the openings of ducts of Bellini (type
2 in this presentation) were crystalline material that com-
pletely filled the lumens of ducts of Bellini and associated
inner medullary collecting ducts (Figs. 1B and D, 2B and
D, and 3A and B). Involved tubules had lumens up to 20




Fig. 1. Endoscopic (A and C) and histologic
(B and D) images showing three distinct pap-
illary patterns of crystal deposits in brushite
patients. (A and C) Examples of papilla from
brushite patients that were video recorded
at the time of the mapping. These papilla
show the irregular white areas of crystalline
deposits (arrows) (type 1 crystal pattern)
beneath the urothelium that we described
for calcium oxalate patients. In addition, the
papilla from brushite patients possesses sites
of a yellowish crystalline deposit at the open-
ings of ducts of Bellini (∗) and in a suburothe-
lial location on the sides of the papilla (double
arrows). Note the enlargement of the opening
of a ducts of Bellini that is filled with crys-
talline material (∗) seen as a depression or
“pit” on the papilla. A large pit (arrowheads)
is seen along the side of the papilla (A) and
does not appear to be associated with a duct
of Bellini. (B and D) Low-magnification light-
microscopic images of a papillary biopsy spec-
imen from a brushite patient are shown; the
sites of calcium deposits were stained black
by the Yasue metal substitution method for
calcium histochemistry. An enormous amount
of Yasue-positive material is seen with ducts
of Bellini (arrows). This crystalline material
is seen protruding from the opening of the
duct of Bellini and also in an associated in-
ner medullary collecting duct (∗). In addition,
Yasue-positive material (B) is in the inter-
stitium of the renal papilla surrounding thin
loops of Henle (double arrows) as we have
previous described for calcium oxalate stone




Fig. 2. Endoscopic (A and C) and histologic
(B and D) images showing the third (type 3)
pattern of crystal deposits in papillary biop-
sies from two brushite patients. During en-
doscopic examination of the renal pelvis, this
pattern of yellowish mineral deposition is
found within lumens of medullary collecting
ducts just like that described for the type 2
pattern, except that these collecting ducts are
located just beneath the urothelium. Sites of
deposit ranged from large areas of crystal de-
position in collecting tubules that formed a
spoke and wheel-like pattern around the cir-
cumference of the papilla (A) (arrows) to
small, single sites of yellowish material in focal
regions of a collecting duct lumen (C) (∗). The
papilla (A and C) also show the type 1 pattern
of whitish crystal deposition that correlate
with interstitial sites of Randall’s plaque (dou-
ble arrow). Histologic analysis of the type 3
deposits (B) confirms that these sites of crystal
deposition are in medullary collecting ducts
(∗) positioned just beneath the urothelium lin-
ing (arrow) of the renal pelvis (A and B). The
collecting ducts (A) are filled with crystalline
material as revealed by the Yasue stain. (B
and D) Yasue-positive material is noted in the
interstitium adjacent to thin loops of Henle
(double arrow) [magnification ×250(B); ×700
(D)].
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times their normal diameter (Figs. 1A, 2B, and 3A and
B), and only a few of the most enlarged tubules were de-
tected in any one biopsy. The openings of involved ducts
were greatly enlarged and filled with crystalline material
that projected into the urinary space (Fig. 1). Some of the
dilated inner medullary collecting ducts extended from
the papillary tip toward the outer medulla (Fig. 3C and
D).
Type 3 yellow suburothelial deposits along the sides of
papillae were outer and inner medullary collecting duct
near the surface of the papilla but not at the point of
tubule fluid egress from Bellini ducts (Figs. 2 and 3). In
other words, yellow deposits were always crystal masses
in collecting duct lumens that differed in geometry be-
cause one is localized in Bellini ducts while other involves
longer lengths of inner and outer medullary collecting
ducts.
Renal papillary cells are abnormal
Tubule cells. Some tubules altogether lacked viable
cells. Cells lining collecting ducts with deposits varied
from irregular shape to complete loss (Fig. 4). Some cells,
all dead, were filled with mineral deposits (Figs. 4 and 5).
Other cells were coated with crystals imbedded in mem-
brane proteins or proteins coating the cell surfaces. Many
coated cells appeared viable, but none had normal mor-
phology (Fig. 5). In particular, nuclei were normal, and
no evidence of apoptotic changes were observed. In the
absence of crystals, collecting ducts cells were invariably
normal.
Interstitium. Cuffing of fibrosis, without chronic in-
flammation (Fig. 1B and D) surrounded individual
isolated collecting ducts with deposits in them. Multi-
ple adjacent collecting ducts contained crystals and ducts
were embedded in large fields of fibrosis containing
chronic inflammatory cells (Figs. 3 and 4). In such re-
gions of dense fibrosis, thin loops of Henle and vasa recta
were injured as indicated by loss of lining cells, greatly
thickened basement membranes, and narrowed tubular
lumens (Fig. 4). Interstitium around normal collecting
duct was without pathologic change.
Papillary pitting reflects dilated ducts of Bellini
Individual papilla often showed depressions (pitting)
near the papillary tip, a phenomenon not observed in cal-
cium oxalate or bypass stone formers. These depressions
or concavities were usually near the openings of ducts of
Bellini that contained crystalline material (Fig. 1A and
C). Histologically, such pits are hugely dilated lumens of
Bellini ducts, enlarged as much as 20 times above nor-
mal by enormous intratubular crystal deposits. In other
words, pitting is part of type 2 deposits. Occasional pits
invaded the sides of a papillary wall and were not asso-
ciated with a duct of Bellini (Fig. 7A). Their histology is
not yet defined.
Pitting, deposits, epithelial cell damage, and interstitial
changes are parallel
Pitting. Because it is the two kinds of pitting that dis-
tort the regular conical shape of the papilla, percent of
papillary pitting is a quantitative gauge of architectural
distortion. Cases 1, 2, 4, 7, and 8 showed a minimal amount
of papillary pitting at 0%, 0.2%, 0.4%, 0.2%, and 0.2%,
respectively. Figure 6 shows all of the papilla (except the
lower lateral papilla which could not be accessed) from
case 1. No evidence of papillary deformity is noted. Cases
3, 5, 6, and 9 showed more extensive papillary pitting at
6%, 3.7%, 21.1%, and 25.7%, respectively. Figure 7 shows
all the papillae from case 5 and that the majority are de-
formed. Case 10 showed an intermediate level of pitting
at 1.6% (not illustrated). These rather coarse groupings
of stone formers by percent pitting have a robust rela-
tionship to the degree of histologic abnormality.
Tubule changes. Although all ten patients had some
tubule crystal plugging, the extent and severity varied
from case to case. Renal tissue from cases 1 and 7, who
had minimal pitting, showed normal inner medulla punc-
tuated by occasional plugged individual collecting duct
segments (Fig. 2C and D). In cases 3, 5, 6, and 9 whose
pitting was more marked, numbers of adjacent tubules
were involved (Fig. 3A and B), not only collecting duct,
but also nearby thin loops of Henle, that were never in-
volved in cases 1 and 7. Moreover, tubule plugging ex-
tended into the outer medulla, a region not involved in
any of our other biopsies (Fig. 3C).
Interstitial changes. Cases 1 and 7, with minimal le-
sions, showed infrequent interstitial fibrosis around soli-
tary enlarged collecting duct filled with crystals (Fig. 2D).
In cases 3, 5, 6, and 9, large regions of interstitial fibro-
sis engulf numerous tubules (Fig. 4A and B). The fibro-
sis expands well beyond the immediate neighborhood of
plugged tubules and surrounds thin loops of Henle that
do not contain crystal plugs. Because we never find in-
terstitial disease in the absence of collecting duct injury,
and interstitial disease is roughly parallel to collecting
duct deposits and injury, we infer that interstitial changes
are a response to collecting injury and not themselves a
primary process.
Intermediate grades of severity (cases 2, 4, 8, and 10).
In cases 2, 8, and 10 some regions contained mild lesions
of isolated plugged collecting ducts surrounded by fo-
cal interstitial fibrosis, and other regions contained the
severe lesions of multiple adjoining plugged collecting
duct with extensive interstitial fibrosis. In other words,
their lesions spanned the range of severity we have en-
countered, whereas cases 3, 5, 6, and 9 had severe lesions
everywhere we sampled, and cases 1 and 7 had only mild
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DC
Fig. 3. Crystal deposition seen by light mi-
croscopy localized to collecting ducts of the
inner (A and B) and outer (C and D) medulla.
(A and B) Yasue-positive material is seen lo-
calized in individual to a small group of inner
medullary collecting ducts (arrows) and occa-
sionally nearby loops of Henle while nearby
duct appear normal (∗). The crystalline mate-
rial greatly expands the tubular lumen of these
tubules. (C and D) Yasue-positive material is
seen extending into the outer medulla where
the crystalline materials is found in the lumens
of outer medullary collecting ducts (arrows)
but in a focal manner such that these crys-
talline tubules are surrounded by many nor-
mal appearing tubules (magnification ×700).
A B
C
Fig. 11. A comparison of histopathogy of
parallel tissue samples from patient 10 fixed
in 100% ethanol (ETOH) (A and B) or 5%
paraformaldehyde in phosphate buffer (PPB)
(pH 7.4) (C). Crystal deposition was identi-
cal in location for both fixatives. Distinct crys-
tals were noted in the basement membranes
of thin loops of Henle (∗) (B and C) and in the
lumens of medullary collecting ducts (A and
C, arrow) (magnification ×900).
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Fig. 4. Interstitial changes accompany
severely injured crystal filled collecting
ducts. All three of these light microscopic
images were obtained from 1l thick plastic
histologic sections of papillary biopsies
from our brushite patients. The tissues (A
and B) were decalcified with 0.1 mol/L
ethylenediaminetetraacetic acid (EDTA)
for 2 months so that the cellular detail of
the crystalline-filled tubules could be more
easily analyzed while (C) is from a calcified
biopsy. (A and B) Extensive cellular damage
is noted in several inner medullary collecting
(arrows) where the mineral had being
chemically removed. These images were
obtained from a papillary biopsy collected
from patient 6 where the gross morphology
of all papilla was severely injured. Extensive
regions of interstitial fibrosis surround the
injured collecting tubules (double arrows).
Entrapped injured thin loops of Henle
and vasa recta (∗) are also noted in these
fields of interstitial fibrosis. (C) A series of
crystalline-filled collecting tubules (arrows)
that are embedded in a small ring of fibrosis
tissues. This tissue was not decalcified so
regions of mineral deposition are easily seen
in this hematoxylin and eosin stained section.
Normal tubular profiles are seen adjacent to
these injured collecting tubules. This sample
was obtained from case 4. An occasional
giant cell (arrowheads) was observed near
damaged collecting ducts as seen in (A)
(magnification ×1100).
lesions. In case 4 all lesions were mild, but all papillae
were abnormal, and lesions involved every region we
sampled (Fig. 3D). In other words, inspection of disease of
intermediate severity supports our findings derived from
an inspection of extremes and suggests that our basic se-
quence of pathogenesis from collecting duct damage to
interstitial fibrosis is not unreasonable.
Cortical changes are more marked in brushite
than other patients
Glomerulosclerosis had progressed to moderate or
global change in eight of the nine brushite stone form-
ers (Table 3). By contrast, intestinal bypass stone formers
had only mild to moderate levels of glomerular pathol-
ogy, and only half of the calcium oxalate stone formers,
and controls, showed any evidence of glomerulosclerosis,
never of more than mild degree. All brushite stone form-
ers displayed some tubular atrophy that was advanced in
six of nine. The controls, calcium oxalate, and intestinal
bypass stone formers showed a minimal level of tubular
atrophy. No cortical interstitial changes were noted in the
controls. The calcium oxalate and intestinal bypass stone
formers possessed a minimal degree of cortical fibrosis. In
marked contrast, all brushite stone formers had moderate
to severe cortical fibrosis. Although of equivalent age, and
reasonably balanced gender ratios, the brushite stone for-
mers harbor a significant level of cortical pathology, with
overt nephron loss, whereas cortical changes in calcium
oxalate and bypass stone formers are more muted, and
controls almost none.
Cortical and papillary changes were not always par-
allel in the brushite stone formers. For example, case 1,
with mild papillary pathology had moderate cortical dis-
ease. Case 2 had severe cortical pathology with intermedi-
ate papillary pathology. Serum creatinine levels (Table 2)
and creatinine clearance values by no means paralleled
cortical changes. Whereas papillary deposits, collecting
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Fig. 5. Transmission electron microscopic
(TEM) changes in crystal-filled collecting
ducts. (A and B) Sections were obtained from
a papillary biopsy from case 6. (C and D) Sec-
tions were obtained from a papillary biopsy
from case 1. (A) The lining cells (∗) of this
decalcified inner medullary collecting tubule
are covered by an electron dense matrix ma-
terial (arrows). A similar area of matrix (ar-
rows) covering the apical cell surface is seen
at a higher magnification (C). The tubular
cells (A) are highly irregular in shape while
the cells (B) are filled with crystal deposits
(∗) and show evidence of injury. (D) A ring
of crystalline material (arrows) is seen filling
the basement membrane and surrounding the
basal surface of a thin loop of Henle, a pat-
tern typical of calcium oxalate stone formers
[magnification ×2800 (A); ×100 (B); ×13000
(C); and ×2800 (D)].
duct cell injury, and interstitial fibrosis seem closely re-
lated, the cortical and papillary abnormalities seem less
so, perhaps because the sampled regions of cortex are not
drained by the sampled regions of papilla.
Statistical analysis of group differences
The foregoing qualitative description of changes in re-
nal cortex can be further quantified by combining atro-
phy and fibrosis into a single score that depicts interstitial
disease (atrophy/fibrosis), and using percent of glomeruli
with moderate or severe changes as a score for glomerular
disease (percent glomerular pathology) (see the Methods
section).
Atrophy/fibrosis. Brushite stone formers had grossly
higher scores (4.1 ± 0.3 vs. 1.4 ± 0.3, 1.3 ± 0.6, and 0,
brushite vs. calcium oxalate, bypass, and control, respec-
tively) than the other three groups (Fig. 8A). Brushite
patients also had more ESWL procedures (3.7 ± 1.0 vs.
0.4 ± 0.1, 2.0 ± 2.0, and 0, brushite vs. calcium oxalate,
bypass, and control, respectively) (Fig. 8C). To evaluate
the hypothesis that the higher atrophy score in brushite
stone formers is due to their larger number of ESWL
procedures, we performed ANOVA with the score as de-
pendent and ESWL and age as covariates. Age was not
significant (P = 0.64), ESWL was marginally significant
(P = 0.059), and the adjusted score of brushite stone for-
mers exceeded that of calcium oxalate stone formers (3.7
± 0.4 vs. 1.7 ± 0.3) (P = 0.001) and also exceeded 0, the
score for controls (P < 0.001) and that for bypass (1.1 ±
0.6) (P = 0.001). Even though brushite stone formers
had more ESWL procedures, ESWL is not sufficient to
account for the higher atrophy/fibrosis score compared
to the other three groups. Homogeneity of slopes was
present for ESWL.
Percent glomerular pathology. Brushite stone formers
had a higher percent glomerular pathology score than
the other three groups (45 ± 11 vs. 5 ± 4, 11 ± 11, and
0, brushite, calcium oxalate, bypass, and control, respec-
tively) (Fig. 8B). By ANOVA with percent pathology
as dependent, age and ESWL as covariates, neither age
nor ESWL were significant confounders (P = 0.74 and
P = 0.80, respectively). Brushite stone formers glomeru-
lar score exceeded that of all three other groups (P =
0.001, P = 0.03, and P = 0.001, calcium oxalate, by-
pass, and control, respectively). Unlike atrophy/fibrosis,
glomerular injury was not related to ESWL, but was
higher in brushite stone formers than the other groups
(Fig. 8C).
The crystal deposits are composed of apatite
l-FTIR analysis. Yasue-positive deposits in the tubu-
lar lumens of medullary collecting ducts and the intersti-
tium around the thin loops of Henle of all ten brushite
stone formers showed primary spectral bands for hy-
droxyapatite and calcium carbonate in both PPB- and
ETOH-treated biopsies (Fig. 9). Spectra from deposits
and the hydroxyl apatite reference material correspond.
The reference material (calcium hydroxyapatite) (Spec-
trum Chemical, Gardena, CA, USA) has a small amount
of calcium carbonate reflected in the presence of bands






Fig. 6. Endoscopic images showing gross morphology of renal papilla of brushite case 1. In the center is an x-ray image of the entire collecting
system with each calyx numbered starting at the upper pole. The gross morphology of individual papilla from this brushite patient that was video
recorded at the time of the mapping is shown. Papilla 1, 3, 4, and 7 are normal appearing in that no sites of deformations (pitting) were seen. These
papilla do show sites of suburothelial white deposits (arrows) we have noted present in calcium oxalate stone patients. In papilla 2 and 5, a few
shallow pits (∗) are seen near the papilla tip. The asterisk denotes the papilla used to indicate access.
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Fig. 7. Endoscopic images showing gross morphology of renal papilla of brushite case 5. In the center is an x-ray image of the entire collecting
system with each calyx numbered starting at the upper pole. The gross morphology of individual papilla from this brushite patient show greater
amount of pitting across much of the papillary surface and more of the papilla are involved than that documented in case 1 (Fig. 6). Papilla 1, 6, 7, 8,
and 10 show severe pitting (arrows) while papilla 2, 3, and 5 show fewer pits (∗). Papilla 4 and 9 only show sites of Randall’s plaque (double arrows).
located near 1400 and 870 cm−1. These features are not
typically observed in spectra of natural hydroxyapatite.
Electron diffraction analysis identified as biologic hy-
droxyapatite (Fig. 10), the crystal deposits in the tubu-
lar lumens of brushite case 5. The electron diffrac-
tion pattern shows the sharp 002 diffraction peak re-
flecting the elongated nature of the crystals and the
broad diffraction band containing the 211, 112, and 300
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Table 3. Cortical pathology of stone formers
Glomerular pathology
Tubular Interstitial
Age Glomeruli Mild Moderate Global atrophy fibrosis
Calcium oxalate
30 2 1 1
63 1 1 1
44 20 1 1
53 21 9 2 2
58 16 2 1 1
74 18 1 1 1
24 6 1 1
41 10 0 0
29 2 0 0
46 1 0 0
27 9 1 1
48 13 2 1 1
61 5 2 1 1
53 6 1 0 0
75 22 4 0 0
Brushite
42(1) 28 19 2 2
42(2) 59 59 3 3
59(3) 17 6 2 3
23(4) 17 6 1 3
42(5)
64(6) 11 6 2 2
52(7) 15 3 1 2
31(8) 24 1 2 2
44(9) 11 3 2 2
39(10) 11 9 1 2
Control
40 29 1 0 0
52 65 0 0
41 100 0 0
71 70 1 0 0
Bypass
52 9 1 1 1
49 27 9 0 0
61 4 1 1 1
Abbreviations: Age, age at papillary biopsy; case number for brushite stone
formers in parentheses; Control subjects; bypass, patients with stones due to
intestinal bypass for obesity; number in parentheses are from a previous report;
glomeruli, number of glomeruli in sample; glomerular pathology, findings about
glomeruli, reported as number of glomeruli in sample showing mild moderate or
global changes (see Methods section); blank, no glomeruli show the changes for
that column; tubular atrophy, and interstitial fibrosis are graded in a scale of 0
to 3 intensity units as noted. Note that cortical tissue was not obtained in one
instance [42(5)] above.
diffraction peaks that are characteristic of biologic apatite
[13].
Crystals are not an artifact of PPB
Parallel tissue samples from case 10 were fixed both us-
ing 5% paraformaldehyde in 0.1 mol/L PPB, and ETOH.
The l-FTIR analysis (Fig. 9) of intratubular crystal de-
posits in parallel sections gave identical spectra from
PPB- and ETOH-fixed tissues. Similarly, Yasue-stained
sections from the same parallel tissue samples fixed in
either PPB or ETOH showed identical patterns of crys-
tal deposition in the basement membrane of thin loops
of Henle and at sites of tubule plugging of medullary col-
lecting duct (Fig. 11). These findings make improbable the
speculation that PPB itself created the crystallizations we
have observed. Since spectra from PPB- and ETOH-fixed
tissues give identical results, it is also difficult to maintain
that PPB produced the apatite we have observed, or mod-
ified the crystal structure.
DISCUSSION
Brushite stone formers have a papillary lesion not
hitherto described
To date, the combination of interstitial apatite plaque
and apatite plugging of collecting duct with cell death
and interstitial fibrosis has not been described. Calcium
oxalate stone formers have interstitial apatite plaque of
a magnitude like that of the brushite stone formers, but
no collecting duct deposits [2]. Our four intestinal by-
pass stone formers [2] all had apatite plugging of col-
lecting ducts, but no interstitial plaque. Their collecting
duct lesions were minor compared to brushite stone for-
mers, whose papillary lesions involve more tubules, larger
masses of crystal, a greater dilation of collecting duct lu-
mens, greater lengths of the renal papillum, more cell
death, and more extensive and severe interstitial inflam-
mation and fibrosis. Perhaps for this reason, we did not
find gross distortions of papillary architecture in the by-
pass patients, as we did here. In other words, brushite
stone formers combine the apatite plaque of calcium ox-
alate stone formers and the collecting duct lesions of by-
pass stone formers in a severe form.
Thus far, only brushite stone formers have significant
renal cortical disease
In addition to severe papillary disease, brushite stone
formers have more glomerulosclerosis, tubular atrophy,
and interstitial fibrosis than calcium oxalate and bypass
stone formers of similar age (Table 3). Clinical measures
might not alert clinicians to the nephron loss that cortical
pathology connotes; creatinine clearances of cases 1, 3, 4,
5, 6, and 8 are low compared to calcium oxalate stone for-
mers and 1, 3, 4, 5, and 6 are low compared to our pool of
brushite stone formers (Table 2); others are normal. The
mean values by gender for our present ten patients are
within the 95% CI for our brushite stone formers pool.
The mean creatinine clearance for the six present male
patients is below the mean for our pool of calcium oxalate
stone formers, while the female mean is within the 95%
CI for our female calcium oxalate stone formers. As ex-
pected serum creatinine levels of our present cases show
corresponding elevations. Creatinine clearance can over
estimate true glomerular filtration rate because of crea-
tinine secretion by renal tubule cells [14], and hyperfil-
tration by remaining nephrons can obscure the reduction
of nephron number. Without biopsy, the extent of renal
damage cannot be gauged. We do not advocate biopsy of
brushite stone formers, but point out the presence of a
renal disease that requires additional study.


























































































Fig. 8. Cortical changes and extracorporeal shock wave lithotripsy (ESWL) procedures. Brushite stone formers had higher cortical atrophy/fibrosis
scores (A) and percent of glomeruli (B) with pathologic changes than controls or calcium oxalate or bypass. They had more ESWL procedures than
controls or calcium oxalate stone formers (C). Values are mean ± SEM.
Histologic changes support a preliminary
pathogenetic scheme
In no instance did we find collecting duct epithelial cell
changes in the absence of crystals, or interstitial changes
in the absence of collecting duct cell changes. Moreover,
we never found crystal deposits without some cell abnor-
mality adjacent to the deposits. Cells coated with crystal
are viable but deformed; those containing crystals are
always dead. Because we never found a viable cell con-
taining internalized crystals, we propose but cannot prove
that crystals entered these cells after death. Therefore, it
is not unreasonable to infer a provisional pathogenetic
sequence: (1) crystallization in collecting duct; (2) crys-
tals contact collecting duct cells; (3) cells are injured; (4)
some collecting duct cells die; (5) crystallization and cell
loss progress to greatly enlarged collecting ducts in the
extreme case; (6) interstitial inflammation is provoked
around injured collecting duct cells; and (7) renal tissue
is sequentially involved. Initial scattered terminal collect-
ing duct plugging is followed by progressive involvement
of medullary structures, including collecting duct, inter-
stitium, vas recta, and thin loops of Henle. Since we never
find cell injury or change without crystals, it is difficult at
this time to propose that cell injury precedes crystalliza-
tion, but there is a caveat: loss of normal pH regulation in
a collecting duct, from obstruction, or other causes could
trigger crystal formation yet not manifest histologically.
The cortical changes, being separate, are of less certain
origin. We propose they may arise from intranephronal
obstruction by crystal deposits and cell damage in the re-
markably strategic locale of the terminal collecting duct.
Only 100 or so Bellini ducts drain the 1 million nephrons
of each human kidney [15], and there are no anatomic by-
pass systems around a blocked duct. The nonspecific cor-
tical changes are compatible with this hypothesis. Chronic
obstruction can lead to exactly this picture [16, 17]. To test
this hypothesis in human tissue would require we demon-
strate some sequence of changes specific to obstruction,
a matter beyond the present work. Of clinical note, the
nonspecific pattern of cortical renal injury could be de-
ceptive if a patient presented with chronic renal failure.
Before this work, no one would consider a past history
of stones as germane to renal disease with cortical scar-
ring. Of course, at this stage, we cannot state that these
patients in particular will have the propensity to progress
to chronic renal failure.
Others have described similar but not identical pathology
The closest example to the brushite lesion that we could
find is yellow deposits in medullary collecting duct in a
single individual with acute lymphatic leukemia and uric
acid nephropathy [18]. Uric acid–plugged tubules lost
lining cells, and nearby interstitium was scarred. Occa-
sional urate crystals were seen in the interstitium associ-
ated with giant cells. Secondary lesions included dilation
of medullary collecting duct, tubular atrophy, and corti-
cal scarring. At the papillary tip linear yellow striations
termed “uric acid infarct” extended from the papillary
tip to the renal fornix. These striations were thought to
represent large amounts of urate and calcium deposits in
medullary collecting duct. Renal cortical changes associ-
ated with distal obstruction of the nephron have been re-
ported in these patients. This lesion differs from brushite
stone formers in lacking apatite interstitial plaque, and, of
course, in the nature of the crystals involved. It occurred
as a consequence of leukemia.
Patients deficient in adenine phosphoribosyltrans-
ferase [19] obstruct their medullary collecting duct and
other tubule segments with deposits of DHA (2,8-
dihydroxyadenine) crystals. All sites of crystal deposits
are associated with progressive cellular damage and
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Fig. 9. Fourier transform infrared microspectroscopy (l-FTIR) spec-
tra of crystal deposits from the brushite patients. A series of infrared
attenuated total internal reflection (ATR) spectra were obtained for
a set of standards (calcium oxalate, brushite, calcium carbonate, and
hydroxyapatite) for a site of calcium deposition (Yasue-positive area)
in the lumen of a inner medullary collecting duct of a brushite patient
fixed in the 5% paraformaldehyde in phosphate buffer (PPB) (pH 7.4),
or 100% ethanol (ETOH), and for the tissue sample fixed in PPB with
embedding media from case 10. The infrared spectra of the Yasue-
positive areas show a spectral band for hydroxyapatite. About a half of
the Yasue-positive areas in tubular lumens also showed a spectral band
for calcium carbonate.
atrophy. Tubular degeneration, inflammation, intersti-
tial fibrosis, and tubular atrophy extend from the renal
medulla to the renal capsule. Like uric acid nephropathy
in the leukemia patient, this is an instructive if somewhat
different situation. The crystallization occurs in many
sites. Being multifocal rather than mainly papillary, it is
not so close a match as the uric acid lesion in the leukemia
patient.
Altogether, the lesions we describe in brushite stone
formers do not have an exact counterpart. Neither of the
two instances noted above bear anything but a superficial
resemblance. Brushite nephropathy is a chronic papillary
and cortical disease of a particular kind of calcium stone
Fig. 10. Transmission electronic microscopic (TEM) electron diffrac-
tion pattern of crystalline deposits in a brushite patient. An area of
intratubular crystal deposition from case 5 was analyzed by electron
diffraction and identified the crystalline material as biologic hydroxya-
patite. It shows the sharp 002 diffraction peak reflecting the elongated
nature of the crystals and the broad diffraction band containing the
211, 112, and 300 diffraction peaks which is a characteristic of biologic
apatites.
former. We believe it is hitherto undescribed in its com-
plete form.
Crystal deposits are not an artifact of tissue preparation
We recognize that because our routine tissue fixation
solution uses a 0.1 mol/L PPB, one could speculate that
the buffer itself caused the crystallizations we present
here. To make certain about buffer artifact, we preserved
parallel tissue samples in buffer and in 100% ETOH, a
fixative that gives inferior histologic results, but avoids the
PPB. Results are definitive in that localization of crystals,
mass of crystals, and infrared spectra of crystals are the
same with buffer and ETOH fixation, excluding buffer as
the source of the deposits.
Surgically observed lesions have specific histologic
counterparts
During PNL in 15 calcium oxalate stone formers [2],
four controls, and the present ten brushite stone form-
ers, it has been an unalterable rule that interstitial ap-
atite plaque is a white, flat suburothelial deposit of lin-
ear to plate like shape. By contrast, because they are
constrained within tubules collecting duct apatite plugs
are yellow, elongate, sausage-shaped, and sometimes
nodular; their boundaries are regular and delimited, in
contrast to the wandering map-like serpiginous shapes of
interstitial plaque. When apatite plugs extend out of the
mouths of ducts of Bellini, their appearances are particu-
larly distinctive, in that they greatly dilate the openings of
these ducts giving the papillary tip a “pitted” appearance.
The number of pits is determined by how many collecting
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ducts are plugged with apatite, and by how much the mass
of deposit has enlarged the size of the lumen. Given the
invariant relationships between appearance and histol-
ogy we have found, clinicians can accurately assess the
tissue basis for crystal deposits seen at surgery.
Etiology is presently speculative
The fact that all brushite stone formers have interstitial
apatite plaque like that found in calcium oxalate stone
formers, and have an additional tubule lesion suggests
brushite and calcium oxalate stone formers share a com-
mon pathogenesis. In fact, some of our brushite stone
formers began with calcium oxalate stones. Urine calcium
levels are generally high in these ten patients (Table 2), as
they are in calcium oxalate stone formers, reflecting the
well-known idiopathic hypercalciuria syndrome [4]. We
propose that the interstitial plaque arises from the same
combination of factors (high urine calcium, reduced urine
volume, and reduced urine pH) we have documented as
correlates of apatite plaque among calcium oxalate stone
formers [3]. For reasons not as yet defined, the brushite
patients deposit apatite in terminal collecting ducts, en-
gendering the pathology of brushite stone disease.
Multiple factors may promote brushite stone forma-
tion. One case (Table 1, case 7) who was a uric acid stone
former, was treated with large amounts of potassium al-
kali, and thereafter formed brushite stones. Another case
(Table 1, case 4) had ureteropelvic obstruction as a child,
with subsequent stones at age 7. Possibly chronic obstruc-
tion caused mild collecting duct cell injury [20].
Some of our patients had many ESWL procedures
(Table 1). ESWL damages collecting duct cells [21], and
renal papillary damage is always present after clinically
relevant dosage of shock waves [22] in experimental an-
imals. Such damage could reduce the ability of collect-
ing ducts to regulate tubule fluid pH [23], so that luminal
pH rises and fosters calcium phosphate crystallization [3].
Our present study cannot test the hypothesis that ESWL
causes brushite stone formation. However, our detailed
analysis of cortical injury does not support the hypoth-
esis that ESWL is sufficient to account for the greater
glomerular and interstitial disease of brushite stone for-
mers. In particular, brushite stone formers have more
cortical pathology allowing for ESWL. Age bore no re-
lationship to cortical pathology. Even so, there was a
general trend among all patients considered together for
greater cortical atrophy/fibrosis as number of ESWL pro-
cedures increased. These results suggest a need for fur-
ther studies of this particular issue.
CONCLUSION
Our work delineates a hitherto undescribed kidney
lesion in stone forming patients. Patients with brushite
stones have interstitial apatite plaque, collecting duct
plugging with apatite, patchy but often severe papil-
lary interstitial fibrosis, and cortical pathology reflect-
ing nephron loss, and are thereby distinguished from the
common calcium oxalate stone formers and from the in-
testinal bypass stone formers. Being a more malignant le-
sion, brushite disease warrants aggressive efforts at stone
prevention. In addition, clinicians may wish to notice that
the type of stone formed can reflect renal pathology and
analyze all stones; many of the present brushite stone
formers initially formed calcium oxalate stones. Investi-
gators may wish to note how essential stone type is for
clinical phenotyping; had we mixed brushite and calcium
oxalate stone formers, we would have missed an impor-
tant point. Far from being a simple disorder within the
urinary tract, stones involve renal crystallizations and tis-
sue diseases we presently understand to only a very lim-
ited extent. Although brushite stone formers constitute
perhaps 5% of all stone formers, millions of people have
stones, so brushite-associated renal disease may not be
rare. Recently, Vupputuri et al [24] have shown in a case-
control study that history of kidney stones may be a risk
factor for chronic kidney disease. Our findings here may
therefore represent one pole of a broad spectrum of re-
nal injuries related to stones in general. Finally, we call
attention to the greater number of ESWL procedures
in our brushite stone formers versus calcium oxalate
stone formers, which may relate in part to the lesions we
describe.
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